Public Health

  Posted on: Monday, July 22, 2019
HHS, DoD, VenatoRx Pharmaceuticals to Co-Develop Antibiotic to Treat Drug-Resistant Infections
Homeland Security Today

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will collaborate with the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA) and VenatoRx Pharmaceuticals, Inc. of Malvern, Pennsylvania, to develop a novel antibiotic to treat infections caused by bacteria resistant to currently available agents.


Read the Full Story
 
Public Health:
11/14/19   Phase 3 trial shows MVA vaccine likely protects against smallpox
11/12/19   Typhoid: Neglect Outside Rich Countries Threatens New Global Health Emergency
11/11/19   Dams Across the U.S. Pose Potential Risk
11/11/19   European Commission grants final approval to Merck's Ebola vaccine
11/11/19   FBI, Partners Brief Pipeline Industry on National Security Threats to Energy Infrastructure
11/8/19   How Emergency Managers Can Meet Challenges of Increasingly Complex Threat Climate
11/8/19   Notes from the Field: Botulism Type E After Consumption of Salt-Cured Fish -- New Jersey, 2018
11/7/19   More than 2 million pounds of chicken products recalled in eight states
11/7/19   Salad Bars and Water Systems Are Easy Targets for Bioterrorists - and America's Monitoring System is Woefully Inadequate
11/1/19   Epidemiological Update - Measles
11/1/19   New Smallpox Vaccine Tested by USAMRIID Receives FDA Approval
10/26/19   Not a Single Country Prepared for Epidemic or Pandemic
10/25/19   More Ebola cases in DRC, including Butembo
10/24/19   U.S., South Korea Partner for Deeper Research on Emergency Preparedness, Pandemics
10/24/19   Vaping-related lung injuries rise to 1,604 cases nationwide, CDC says
10/23/19   BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
10/22/19   VA study finds contact precautions don't affect MRSA in long-term care
10/22/19   What Can We Glean from a Bean: Ricin's Appeal to Domestic Terrorists
10/19/19   CWMD Has 'Spun Down Worse and Worse' with 'Flawed' Biothreat Detection, Lawmakers Told
10/18/19   FDA Allows Marketing of First Rapid Diagnostic Test for Detecting Ebola Virus Antigens
Search Archives:



The St. Louis Fusion Center: Terrorism Early Warning Group is an information sharing initiative owned and operated by the  St. Louis Fusion Center. 
Should you have any questions please email info@sltew.org.

© 2019 St. Louis Fusion Center: Terrorism Early Warning Group. All rights reserved.